PCOS Has a New Name: What PMOS Means
PCOS Just Got a New Name. Here's What “PMOS” Finally Admits About Your Symptoms
For years you were told it was about your ovaries. The new name says it's about your whole metabolism, and that changes how a lot of women are thinking about daily support.
About 170 million women worldwide live with the condition now called PMOS.
If you were diagnosed with PCOS, you probably remember what came next. A prescription, maybe a pamphlet, and the advice to “lose some weight.” Almost nobody explained why you had the acne, the chin hair, the cycles that came whenever they felt like it, and the energy crash every afternoon.
In May 2026, a global group of experts published a new name for the condition in The Lancet: Polyendocrine Metabolic Ovarian Syndrome, or PMOS. The process took about a decade and pulled in patients, clinicians and researchers from around the world.
The old name pointed at cysts. The new one points at hormones and metabolism, which is what a lot of women were living with all along.
Why the name change matters
“Polycystic” never fit well. Many women with the condition don't have ovarian cysts at all, and the name hid the part that shows up in daily life: how your body handles insulin, and how that ripples into your other hormones.
“Polyendocrine” means several hormone systems are involved. “Metabolic” puts blood sugar and insulin at the center. For many women, that's the first time the name has matched what they feel.
What women with PMOS commonly deal with
- Cycles that are irregular, late, or missing
- Breakouts along the jaw and chin
- Unwanted facial or body hair
- Bloating, cravings and afternoon energy crashes
- Weight that seems to ignore your effort
So where does daily support come in?
PMOS is a medical condition, and your doctor should be your first call for diagnosis and treatment. But more women are also asking a practical question: what can I add to my routine that works with my body's metabolism instead of against it?
One nutrient keeps coming up in that conversation: inositol. It's a vitamin-like compound your body already uses in insulin signaling, and it's one of the most studied nutrients among women with PCOS/PMOS.
The new name puts metabolism at the center. That's where inositol fits.
The problem: most women quit before it can help
The trouble is the routine. A lot of inositol products are powders you mix twice a day, plus separate bottles for vitamin D, zinc and whatever else your group chat recommends. Most women we talk to tried it and gave up within a few weeks.
Sisters Nutrition built one thing you'd actually take every day: a single gummy with inositol and the other nutrients women with PMOS ask about most.
What's inside Cystaway Gummies
Two tropical-rosé gummies a day. Vegan, with no artificial flavors, synthetic colors, dairy or high-fructose corn syrup.
What women are saying
Rated 4.8 stars from 4,400+ reviews. A couple of them:
Individual results vary. Customers commonly report changes in energy within 2–4 weeks and in skin and cycles over 2–3 months of consistent daily use.
Is it right for you?
If you've been diagnosed with PMOS/PCOS and you want a simple, daily nutrient routine alongside your doctor's care, it's worth trying. If you're pregnant, nursing, or on medication, check with your doctor first. That's good advice for any supplement.
Try Cystaway Gummies today
- ✓ Save 33% when you subscribe ($26.13/bag)
- ✓ Skip, pause or cancel anytime
- ✓ Free shipping on the 3-month supply
- ✓ Easy 30-day returns on unused items
You'll see current pricing on the next page before you check out.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for general information and isn't medical advice. Talk to your healthcare provider about diagnosis and treatment of PMOS/PCOS.
Sources: Teede HJ et al., “Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process,” The Lancet, 2026. STAT News, May 12, 2026.